Clinical Trial Update: A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating intratumoral influenza vaccine administration in patients with breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Rush University Medical Center | Conditions: Breast Cancer, Breast Cancer Triple Negative | Phase 1 | Status: WITHDRAWN